Elekta (OTCMKTS:EKTAY) Shares Gap Down – What’s Next?

Elekta AB (OTCMKTS:EKTAY)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $5.24, but opened at $4.88. Elekta shares last traded at $4.88, with a volume of 5,426 shares trading hands.

Analyst Ratings Changes

Separately, Zacks Research cut Elekta from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 2nd. Two analysts have rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Elekta Trading Down 7.9%

The company has a debt-to-equity ratio of 0.47, a current ratio of 0.87 and a quick ratio of 0.68. The business’s 50-day moving average is $5.61 and its two-hundred day moving average is $5.97. The firm has a market cap of $1.80 billion, a P/E ratio of -30.44 and a beta of 1.01.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings data on Thursday, May 28th. The company reported $0.06 EPS for the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. The company had revenue of $521.00 million during the quarter. As a group, analysts predict that Elekta AB will post 0.43 earnings per share for the current fiscal year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.